rs4358188

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001725.3(BPI):​c.634G>A​(p.Glu212Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.476 in 1,612,388 control chromosomes in the GnomAD database, including 185,568 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.48 ( 17923 hom., cov: 32)
Exomes 𝑓: 0.48 ( 167645 hom. )

Consequence

BPI
NM_001725.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.10
Variant links:
Genes affected
BPI (HGNC:1095): (bactericidal permeability increasing protein) This gene encodes a lipopolysaccharide binding protein. It is associated with human neutrophil granules and has antimicrobial activity against gram-negative organisms. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.4498378E-5).
BP6
Variant 20-38318446-G-A is Benign according to our data. Variant chr20-38318446-G-A is described in ClinVar as [Benign]. Clinvar id is 402434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BPINM_001725.3 linkc.634G>A p.Glu212Lys missense_variant Exon 6 of 15 ENST00000642449.2 NP_001716.3 P17213

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BPIENST00000642449.2 linkc.634G>A p.Glu212Lys missense_variant Exon 6 of 15 NM_001725.3 ENSP00000494528.2 A0A2R8YDF1

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73171
AN:
151872
Hom.:
17936
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.503
Gnomad AMI
AF:
0.597
Gnomad AMR
AF:
0.444
Gnomad ASJ
AF:
0.406
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.570
Gnomad MID
AF:
0.417
Gnomad NFE
AF:
0.485
Gnomad OTH
AF:
0.439
GnomAD3 exomes
AF:
0.457
AC:
114929
AN:
251394
Hom.:
27241
AF XY:
0.464
AC XY:
62974
AN XY:
135866
show subpopulations
Gnomad AFR exome
AF:
0.504
Gnomad AMR exome
AF:
0.385
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.225
Gnomad SAS exome
AF:
0.497
Gnomad FIN exome
AF:
0.560
Gnomad NFE exome
AF:
0.485
Gnomad OTH exome
AF:
0.456
GnomAD4 exome
AF:
0.475
AC:
694061
AN:
1460398
Hom.:
167645
Cov.:
53
AF XY:
0.477
AC XY:
346556
AN XY:
726588
show subpopulations
Gnomad4 AFR exome
AF:
0.507
Gnomad4 AMR exome
AF:
0.391
Gnomad4 ASJ exome
AF:
0.398
Gnomad4 EAS exome
AF:
0.207
Gnomad4 SAS exome
AF:
0.504
Gnomad4 FIN exome
AF:
0.559
Gnomad4 NFE exome
AF:
0.484
Gnomad4 OTH exome
AF:
0.461
GnomAD4 genome
AF:
0.481
AC:
73167
AN:
151990
Hom.:
17923
Cov.:
32
AF XY:
0.482
AC XY:
35832
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.502
Gnomad4 AMR
AF:
0.444
Gnomad4 ASJ
AF:
0.406
Gnomad4 EAS
AF:
0.220
Gnomad4 SAS
AF:
0.513
Gnomad4 FIN
AF:
0.570
Gnomad4 NFE
AF:
0.485
Gnomad4 OTH
AF:
0.433
Alfa
AF:
0.471
Hom.:
36215
Bravo
AF:
0.468
TwinsUK
AF:
0.478
AC:
1774
ALSPAC
AF:
0.472
AC:
1821
ESP6500AA
AF:
0.502
AC:
2214
ESP6500EA
AF:
0.492
AC:
4228
ExAC
AF:
0.462
AC:
56132
Asia WGS
AF:
0.356
AC:
1239
AN:
3478
EpiCase
AF:
0.467
EpiControl
AF:
0.466

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.041
DANN
Benign
0.68
DEOGEN2
Benign
0.0044
T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0025
N
LIST_S2
Benign
0.37
T;T
MetaRNN
Benign
0.000014
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-2.0
N;.
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.10
N;.
REVEL
Benign
0.20
Sift
Benign
1.0
T;.
Sift4G
Benign
1.0
T;T
Polyphen
0.0010
B;.
Vest4
0.071
MPC
0.054
ClinPred
0.0012
T
GERP RS
0.59
Varity_R
0.11
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4358188; hg19: chr20-36946848; COSMIC: COSV53404412; COSMIC: COSV53404412; API